Archive by category | – Matthew Chervenak

China’s biotech landscape

China's biotech landscape

Since coming to China in 2002, I have witnessed incredible growth within China’s biotechnology industry. The ecosystem has emerged from a collection of companies with mixed innovator/service business models and poor communication skills to a stratified, differentiated landscape with an international impact. Some of the players have since gone public. Others have raised VC rounds internationally. Deals between Chinese companies and global pharmaceutical and biotechnology companies are common. Many small private companies are thriving. China biotech has arrived.  Read more